SEC EDGARAug 4$CHE

MCNAMARA KEVIN J sold $1.1M of CHE

MCNAMARA KEVIN J (president and CEO) sold 2,000 shares of CHEMED CORP (CHE) at $539.51 ($1.08M total) on 2026-08-03.

Original reporting

SEC EDGAR · MCNAMARA KEVIN J

Published Aug 4, 2026, 1:24 PM UTC

Analysis

AlphAI AI DeskAI-generated

Added to AlphAI Aug 4, 2026, 1:33 PM UTC. Informational, not investment advice.

How this was made

AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.

About AlphAI AI Desk Scoring methodology Report an issue

AlphAI market briefInsider activity

Primary signal

$CHE

Neutral

medium confidence

Mentioned

$CHE

Relevance

6/10

AlphAI data visualization · based on SEC EDGAR

Decision brief

The 30-second read

$CHENeutralLow

Why it matters

Traders may monitor for follow-on insider activity or correlate with upcoming company events, but the text alone does not provide a new operating or financial catalyst.

Market read

A CEO open-market sale of about $1.08M is disclosed, which can slightly pressure sentiment but lacks fundamental context in the provided text.

What to watch

The filing does not state the reason for the sale, and it explicitly notes no pre-arranged 10b5-1 plan, which can increase headline sensitivity without proving intent or information.

Relevance 6/10Novelty 5/10Timing: filed 2026-08-04, covering a sale dated 2026-08-03

Background

The article is a SEC Form 4 insider transaction disclosure for Chemed Corp, reported by its president and CEO.

Company-level read

Ticker impact

AI estimates · verify against primary disclosures

$CHENeutralMedium confidence

Context

Chemed Corp CEO Kevin J. McNamara filed a Form 4 selling 2,000 shares at $539.51 on 2026-08-03, totaling about $1.08M.

Expected impact

Low likelihood of a sustained price move; any reaction is likely limited to short-term sentiment around insider selling.

Evidence & confidence

The filing is primary-source and time-stamped, but the article provides no accompanying earnings, guidance, legal, or operational catalyst. Insider sales are common and the text does not indicate distress or a company-specific event.

Market effects

Sector

Minimal, as the disclosure is company-specific insider activity with no sector-wide signal.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

The sale could be routine liquidity management (taxes, diversification) and does not necessarily reflect a bearish view on Chemed’s fundamentals.

Key entities

issuer
CHEMED CORP
US-listed issuer referenced in the Form 4 insider transaction.
insider
KEVIN J MCNAMARA
President and CEO who sold 2,000 shares in an open-market transaction.

Read at source ← All news

$CHEMedAI 9/10

Chemed 3Q 2026: Revenue $690.9M, EPS $5.45— 10-Q Summary

Chemed reported Q3 2026 revenue of $690.9M, up 10.6% YoY, with net income rising 11.5% to $71.6M and EPS increasing 22.2% to $5.45. Growth in VITAS and Roto-Rooter segments drove results, while higher fuel costs pressured margins. The company acquired RotoCo and other franchises, expanding its territories.

tradingview.comOct 29

$CHEMed

What Chemed (CHE) Said on Its Q3 Earnings Call

Chemed reported Q3 earnings, with Roto-Rooter revenue up 7.5% but EBITDA down 2.5% due to higher costs. Commercial revenue grew 9% to $59.9M, while residential rose 5.2% to $158.8M. The company acquired California franchises for $62.5M, expecting $30M-$35M in 2027 revenue but less than $4M in EBITDA. Chemed repurchased 125,000 shares for $66M. Management expects 2026 EPS to meet or slightly exceed guidance.

finance.yahoo.comOct 29

$CHEHigh

Chemed Corp (CHE) Q3 2026 Earnings Call Highlights: VITAS Strength Drives 28% EPS Growth

Chemed Corp (CHE) reported Q3 2026 earnings with VITAS driving 28% EPS growth. Roto-Rooter saw a 2.5% EBITDA decline due to higher marketing and fuel costs. VITAS faces regulatory audits, reviewing $12-$14M in revenue. Chemed anticipates continued cost headwinds in Q4. Management discussed hiring, acquisitions, and lead generation strategies.

finance.yahoo.comOct 28

$CHEMed

Chemed outlines 12- to 18-month integration timeline for $62.5M California Roto-Rooter franchise buyback while expecting 2026 EPS at or slightly above prior high end (NYSE:CHE)

Chemed (CHE) announced a 12- to 18-month integration timeline for its $62.5M California Roto-Rooter franchise buyback. CEO Kevin McNamara reported VITAS revenue grew 12.2% year-over-year, driven by ADC growth and cost containment. The company expects 2026 EPS to be at or slightly above the prior high end.

seekingalpha.comOct 28

$CHEHighAI 8/10

Chemed (CHE) Q3 2026 Earnings Call Transcript

Chemed (CHE) reported Q3 2026 earnings with total revenue up 10.6% and adjusted EPS up 28.1% YoY. VITAS saw 12.2% revenue growth, while Roto Rooter grew 7.5%. Roto Rooter's margins declined due to higher marketing costs and fuel expenses, but acquisitions are expected to drive long-term growth. The company has $229M in cash flow from operations, enabling strategic acquisitions and share repurchases.